• Services
    • Overview
    • Antibody Profiling Solutions
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-Oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Disease and Treatment Outcome Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • Antibodies as Biomarkers
    • Bioinformatics for Antibody Profiling
  • Resources
    • Blog
    • Videos
    • Featured Publications
    • Product Information
    • White Paper & Case Studies
    • Protein List
    • FAQs
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

Webinar: B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC

January 29, 2023
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2023-01-29 22:15:102024-02-27 20:39:05Webinar: B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC

British Society for Immunology Congress 2022. Visit us at booth #17.

November 15, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-11-15 02:02:472022-11-15 02:23:43British Society for Immunology Congress 2022. Visit us at booth #17.

50th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology.

November 15, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-11-15 01:58:572022-11-15 02:06:4950th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology.

Sengenics will be exhibiting at the Neuroscience 2022. Visit us at booth #621.

September 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-09-02 00:33:262022-11-15 02:23:55Sengenics will be exhibiting at the Neuroscience 2022. Visit us at booth #621.

Sengenics will be exhibiting at the Frontiers in Cancer Science in Singapore. Get in touch to plan a meeting.

September 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-09-02 00:32:332022-09-02 00:32:34Sengenics will be exhibiting at the Frontiers in Cancer Science in Singapore. Get in touch to plan a meeting.

Sengenics will be exhibiting at the ELRIG Drug Discovery UK 2022. Get in touch to plan a meeting.

September 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-09-02 00:28:332022-09-02 00:30:51Sengenics will be exhibiting at the ELRIG Drug Discovery UK 2022. Get in touch to plan a meeting.

Sengenics will be exhibiting at the Biomarkers US 2022. Visit us at booth #8.

September 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-09-02 00:24:362022-09-02 00:27:35Sengenics will be exhibiting at the Biomarkers US 2022. Visit us at booth #8.

Sengenics will be exhibiting at the Immuno UK 2022. Visit us at booth #16.

September 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-09-02 00:21:312022-09-02 00:28:21Sengenics will be exhibiting at the Immuno UK 2022. Visit us at booth #16.

Sengenics will be exhibiting at the 16th World Immune Regulation Meeting. Visit us at booth #116.

July 2, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-07-02 22:56:292022-07-05 02:21:46Sengenics will be exhibiting at the 16th World Immune Regulation Meeting. Visit us at booth #116.

Sengenics will be sponsoring the Precision Medicine World Conference 2022. Visit us at booth #A110.

April 11, 2022
/wp-content/uploads/2022/02/Component-29-–-8.svg 0 0 kamil /wp-content/uploads/2022/02/Component-29-–-8.svg kamil2022-04-11 03:04:212022-05-24 03:13:48Sengenics will be sponsoring the Precision Medicine World Conference 2022. Visit us at booth #A110.
Page 2 of 3123

Follow us on Facebook

i-Ome Protein Array

Advertise hereAdvertise here

Blog Posts

  • December 2024 (1)
  • September 2024 (1)
  • August 2024 (4)
  • July 2024 (1)
  • June 2024 (4)
  • April 2024 (1)
  • February 2024 (1)
  • October 2023 (1)
  • August 2023 (1)
  • June 2023 (2)
  • March 2023 (1)
  • January 2023 (3)
  • November 2022 (3)
  • September 2022 (6)
  • July 2022 (1)
  • April 2022 (9)
  • March 2022 (1)
  • December 2021 (1)
  • May 2021 (1)
  • March 2021 (1)
  • December 2020 (1)
  • October 2020 (2)
  • June 2020 (2)
  • March 2020 (1)
  • January 2020 (1)
  • December 2019 (1)
  • November 2019 (1)
  • July 2019 (1)
  • October 2018 (1)
  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

"*" indicates required fields

Fill in the form to download the publication

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.